Clinical Trials Update: Nov. 22, 2006
1816
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
424951
NEW YORK - A new round of trials have shown a boosted risk of heart problems among patients taking the painkiller Celebrex, manufacturer Pfizer Inc.
90458
The move comes ahead of a House hearing this week where, it is expected, drug companies will be excoriated for refusing to publish unfavorable clinical trial results.
362077
Clinical trial data released by pharmaceutical company Boehringer Ingelheim at the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy in Washington, DC, on its experimental protease inhibitor tipranavir show that the drug is effective
380219
New board will focus on safety of drugs already on the market. Also: Flarion makes bold moves to spur expansion of infrastructure for its mobile data technology.... Texas Instruments can make cheaper 3G phones.... and more.
714498
Tropical Medicine in London, in research published online by The Lancet medical journal on Thursday. not new and had been made in many of the product-liability lawsuits filed against Philip Morris.
153875
BOSTON, Oct. 29 /PRNewswire/ -- Data to be presented at the 55th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) demonstrated that treatment with the Bristol-Myers Squibb
535175
BioSante releases more info on the pivotal studies for its lead drug.
403859
TUESDAY, Oct. 5 (HealthDayNews) -- A trial for what appeared to be a promising new therapy for Parkinson's disease has been halted, although researchers haven't given up hope that the drug will one day prove useful.
383170
Human Genome Sciences, Inc. announced today that it has begun dosing patients in a Phase 2 clinical trial of HGS-ETR1 (agonistic human monoclonal antibody to TRAIL Receptor 1) in patients with advanced ...
388102
Pre-clinical trial results are mixed, but mark a major step forward for developing human treatments.
143996
For patients weary of scary headlines about popular treatments like the heart drug Vytorin, a new report issued on Thursday by U.S. Institute of Medicine may offer welcome relief.
95097
NEW YORK -- The pharmaceutical industry yesterday said it plans to publish more data about clinical drug trials, despite skepticism about whether the initiative will increase transparency and improve drug safety.
34476
MONDAY, July 2 (HealthDay News) -- New research may someday provide another treatment option for patients battling deadly pancreatic cancer.
753810
Amid growing concerns, the maker of the widely sold arthritis drug announced Monday that it will soon begin a major clinical trial to determine whether the drug is safe for long-term use.
303689
Acorda announces positive clinical trial data.
706106
By Linda Loyd, The Philadelphia Inquirer  Dec. 7--Auxilium Pharmaceuticals Inc. said it has temporarily suspended a late-stage clinical trial of its injectable drug, AA4500, for Dupuytren's disease, a rare finger joint condition, to investigate a manufacturing issue.